Article
A serum-based DNA methylation assay provides accurate detection of glioma
3 Feb 2021
Abstract excerpt
BACKGROUND: The detection of somatic mutations in cell-free DNA (cfDNA) from liquid biopsy has emerged as a noninvasive tool to monitor the follow-up of cancer patients. However, the significance of cfDNA clinical utility remains uncertain in patients with brain tumors, primarily because of the limited sensitivity cfDNA has to detect real tumor-specific somatic mutations. This unresolved challenge has prevented...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
